FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978294054> ?p ?o ?g. }

• W1978294054 endingPage "657" @default.
• W1978294054 startingPage "651" @default.
• W1978294054 abstract "Objective. The aim of this study was to determine pathologic variables associated with disease-specific survival of node-positive patients with endometrial carcinoma treated with combination of surgery including pelvic and para-aortic lymphadenectomy and adjuvant chemotherapy. Methods. Survival of 55 node-positive endometrial carcinoma patients prospectively treated with surgery and adjuvant chemotherapy between 1982 and 2002 at Hokkaido University Hospital was compared to various histopathologic variables. All patients underwent primary surgical treatment including pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy consisting of intravenous cisplatin, doxorubicin, and cyclophosphamide. Survival analyses were performed by the Kaplan–Meier curves and the log-rank test. Independent prognostic factors were determined by multivariate Cox regression analysis using a forward stepwise selection. Results. Among 303 consecutive endometrial cancer patients treated during the period of this study, 55 patients (18.2%), including 44 without peritoneal metastasis (FIGO stage IIIc) and 11 with peritoneal metastasis (FIGO stage IV), were found to have retroperitoneal lymph node metastasis. Multivariate Cox regression analysis revealed that peritoneal metastasis and lymph-vascular space invasion (LVSI) were independently related to poor survival in node-positive endometrial carcinoma. The estimated 5-year survival rate of stage IIIc patients with or without moderate/prominent LVSI was 50.9% and 93.3%, respectively with statistically significant difference (P = 0.0024). The estimated 5-year survival rate of stage IV patients was 20.0%. Prognosis of stage IIIc patients could be stratified into three groups by the number of positive para-aortic node (PAN) with an estimated 5-year survival rate of 86.4% for no positive PAN (n = 23), 60.4% for one positive PAN (n = 13), and 20.0% for ≥ 2 positive PAN (n = 8). The difference of survival rate between no or one positive PAN and ≥ 2 positive PAN was statistically significant (P = 0.0007 for no positive PAN vs ≥ 2 positive PAN, P = 0.0319 for one positive PAN vs ≥ 2 positive PAN). Multivariate analysis including number of positive PAN groups showed that LVSI, number of positive PAN groups were independent prognostic factors for survival. Survival of patients with stage IIIc disease could be stratified into three groups by combination of LVSI and number of positive PAN groups with an estimated 5-year survival rate of 93.3% for no or one positive PAN group with nil or minimal LVSI, 62.6% for no or one positive PAN group with intermediate or prominent LVSI, and 20.0% for ≥ 2 positive PAN groups irrespective of LVSI (P = 0.0002 for no or one positive PAN group with nil or minimal LVSI vs ≥ 2 positive PAN groups, P = 0.0223 for no or one positive PAN group with nil or minimal LVSI vs no or one positive PAN group with intermediate or prominent LVSI, P = 0.0388 for no or one positive PAN group with intermediate or prominent LVSI vs ≥ 2 positive PAN groups). Conclusions. LVSI and number of positive PAN groups were independent prognostic factors for stage IIIc endometrial cancer patients. Postoperative therapy and follow-up modality need to be individualized according to LVSI and the number of positive PAN for stage IIIc patients. New molecular markers to predict the prognosis of endometrial cancer patients preoperatively should be found for individualization of treatment. New chemotherapy regimen including taxane needs to be considered as an adjuvant therapy for patients with node-positive endometrial cancer." @default.
• W1978294054 created "2016-06-24" @default.
• W1978294054 creator A5007970315 @default.
• W1978294054 creator A5009010132 @default.
• W1978294054 creator A5017593738 @default.
• W1978294054 creator A5036752654 @default.
• W1978294054 creator A5046213781 @default.
• W1978294054 creator A5049814584 @default.
• W1978294054 date "2005-03-01" @default.
• W1978294054 modified "2023-10-02" @default.
• W1978294054 title "Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer" @default.
• W1978294054 cites W1966702850 @default.
• W1978294054 cites W1990493051 @default.
• W1978294054 cites W2001324595 @default.
• W1978294054 cites W2006680628 @default.
• W1978294054 cites W2012477754 @default.
• W1978294054 cites W2016558284 @default.
• W1978294054 cites W2018455463 @default.
• W1978294054 cites W2031422053 @default.
• W1978294054 cites W2036480643 @default.
• W1978294054 cites W2041785837 @default.
• W1978294054 cites W2043012914 @default.
• W1978294054 cites W2046111753 @default.
• W1978294054 cites W2046569169 @default.
• W1978294054 cites W2109694492 @default.
• W1978294054 cites W4247042245 @default.
• W1978294054 doi "https://doi.org/10.1016/j.ygyno.2004.11.026" @default.
• W1978294054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15721407" @default.
• W1978294054 hasPublicationYear "2005" @default.
• W1978294054 type Work @default.
• W1978294054 sameAs 1978294054 @default.
• W1978294054 citedByCount "68" @default.
• W1978294054 countsByYear W19782940542012 @default.
• W1978294054 countsByYear W19782940542013 @default.
• W1978294054 countsByYear W19782940542014 @default.
• W1978294054 countsByYear W19782940542015 @default.
• W1978294054 countsByYear W19782940542016 @default.
• W1978294054 countsByYear W19782940542017 @default.
• W1978294054 countsByYear W19782940542018 @default.
• W1978294054 countsByYear W19782940542022 @default.
• W1978294054 crossrefType "journal-article" @default.
• W1978294054 hasAuthorship W1978294054A5007970315 @default.
• W1978294054 hasAuthorship W1978294054A5009010132 @default.
• W1978294054 hasAuthorship W1978294054A5017593738 @default.
• W1978294054 hasAuthorship W1978294054A5036752654 @default.
• W1978294054 hasAuthorship W1978294054A5046213781 @default.
• W1978294054 hasAuthorship W1978294054A5049814584 @default.
• W1978294054 hasConcept C121608353 @default.
• W1978294054 hasConcept C126322002 @default.
• W1978294054 hasConcept C126894567 @default.
• W1978294054 hasConcept C143998085 @default.
• W1978294054 hasConcept C146357865 @default.
• W1978294054 hasConcept C151730666 @default.
• W1978294054 hasConcept C2776283816 @default.
• W1978294054 hasConcept C2776694085 @default.
• W1978294054 hasConcept C2777088508 @default.
• W1978294054 hasConcept C2777546739 @default.
• W1978294054 hasConcept C2777982462 @default.
• W1978294054 hasConcept C2779013556 @default.
• W1978294054 hasConcept C2780824555 @default.
• W1978294054 hasConcept C2780849966 @default.
• W1978294054 hasConcept C50382708 @default.
• W1978294054 hasConcept C71924100 @default.
• W1978294054 hasConcept C86803240 @default.
• W1978294054 hasConcept C90924648 @default.
• W1978294054 hasConceptScore W1978294054C121608353 @default.
• W1978294054 hasConceptScore W1978294054C126322002 @default.
• W1978294054 hasConceptScore W1978294054C126894567 @default.
• W1978294054 hasConceptScore W1978294054C143998085 @default.
• W1978294054 hasConceptScore W1978294054C146357865 @default.
• W1978294054 hasConceptScore W1978294054C151730666 @default.
• W1978294054 hasConceptScore W1978294054C2776283816 @default.
• W1978294054 hasConceptScore W1978294054C2776694085 @default.
• W1978294054 hasConceptScore W1978294054C2777088508 @default.
• W1978294054 hasConceptScore W1978294054C2777546739 @default.
• W1978294054 hasConceptScore W1978294054C2777982462 @default.
• W1978294054 hasConceptScore W1978294054C2779013556 @default.
• W1978294054 hasConceptScore W1978294054C2780824555 @default.
• W1978294054 hasConceptScore W1978294054C2780849966 @default.
• W1978294054 hasConceptScore W1978294054C50382708 @default.
• W1978294054 hasConceptScore W1978294054C71924100 @default.
• W1978294054 hasConceptScore W1978294054C86803240 @default.
• W1978294054 hasConceptScore W1978294054C90924648 @default.
• W1978294054 hasIssue "3" @default.
• W1978294054 hasLocation W19782940541 @default.
• W1978294054 hasLocation W19782940542 @default.
• W1978294054 hasOpenAccess W1978294054 @default.
• W1978294054 hasPrimaryLocation W19782940541 @default.
• W1978294054 hasRelatedWork W167319750 @default.
• W1978294054 hasRelatedWork W1758517966 @default.
• W1978294054 hasRelatedWork W1978015204 @default.
• W1978294054 hasRelatedWork W2017080354 @default.
• W1978294054 hasRelatedWork W2369251192 @default.
• W1978294054 hasRelatedWork W2373471017 @default.
• W1978294054 hasRelatedWork W2898594549 @default.
• W1978294054 hasRelatedWork W2947416310 @default.
• W1978294054 hasRelatedWork W4230836644 @default.
• W1978294054 hasRelatedWork W2146615717 @default.

• next